Monitoring of leukemia growth in a rat model using a highly sensitive assay for the detection of LacZ marked leukemic cells.
A very sensitive assay for the detection of LacZ marked cells of an in vitro growing subline of the brown Norway rat myelocytic leukemia (BNML) model was developed. By combining cytochemical X-gal staining with D-galactose mediated suppression of endogenous background beta-galactose activity, a detection sensitivity of one leukemic cell per 10(8) normal bone marrow cells could be achieved. A detailed analysis of the in vivo growth pattern and kinetics of this cell line is presented. Also, it is shown that after cyclophosphamide treatment of leukemic rats no leukemic colonies are formed in an agar-colony assay, whereas the leukemic cells remain detectable in the bone marrow for a considerable time period. Eventually, however, all leukemic cells disappear from the marrow. These findings are discussed in the light of prolonged detection of rare leukemic cells in patients in continuing remission.
D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D015415:Biomarkers; D003520:Cyclophosphamide / Q000627:therapeutic use; D007942:Leukemia, Experimental / Q000473:pathology*; D007951:Leukemia, Myeloid / Q000473:pathology*; D008722:Methods; D051381:Rats; D011914:Rats, Inbred BN; D014407:Tumor Cells, Cultured; D001616:beta-Galactosidase / Q000032:analysis
D018906:Antineoplastic Agents, Alkylating; D015415:Biomarkers; D003520:Cyclophosphamide; D001616:beta-Galactosidase